Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism-Reference-Cited by-同舟云学术

Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism

Published:2015-12-04 Issue:2 Volume:7 Page:1878-1894
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Braadland Peder Rustøen¹,Grytli Helene Hartvedt¹,Ramberg Håkon¹,Katz Betina²,Kellman Ralf³,Gauthier-Landry Louis⁴,Fazli Ladan⁵,Krobert Kurt Allen⁶⁷,Wang Wanzhong⁸,Levy Finn Olav⁶⁷,Bjartell Anders⁹¹⁰,Berge Viktor¹¹,Rennie Paul S.⁵,Mellgren Gunnar³¹²,Mælandsmo Gunhild Mari¹¹³,Svindland Aud²¹⁴,Barbier Olivier⁴,Taskén Kristin Austlid¹¹⁴

Affiliation:

1. Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

2. Department of Pathology, Oslo University Hospital, Oslo, Norway

3. Hormone Laboratory, Haukeland University Hospital, Bergen, Norway

4. Laboratory of Molecular Pharmacology, CHU-Québec Research Center and Faculty of Pharmacy, Laval University, Québec, Canada

5. The Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada

6. Department of Pharmacology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway

7. K.G. Jebsen Cardiac Research Centre and Center for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway

8. Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden

9. Department of Urology, Skåne University Hospital, Malmø, Sweden

10. Department of Clinical Sciences Malmø, Division of Urological Cancers, Lund University, Lund, Sweden

11. Department of Urology, Oslo University Hospital, Oslo, Norway

12. Department of Clinical Science, University of Bergen, Bergen, Norway

13. Institute for Pharmacy, Faculty of Health Science, University of Tromsø, Tromsø, Norway

14. Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the roles of cAMP signalling in the progression of prostate cancer;Biochemical Journal;2023-10-13

2. Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling;Breast Cancer Research;2022-05-14

3. Tumor-Nerve Interface: An Emerging Therapeutic Intervention Point for Solid Cancers;Interdisciplinary Cancer Research;2022

4. Implication of β2-adrenergic receptor and miR-196a correlation in neurite outgrowth of LNCaP prostate cancer cells;PLOS ONE;2021-06-30

5. Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2020-12